menu
    • menu

    Company profile for DONG BANG FUTURE TECH & LIFE CO., LTD

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DONG BANG FUTURE TECH & LIFE CO., LTDkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    78, Jeyakogongdan 4-Gil, Hyangnam-Eup,
    Telephone
    Telephone
    82 274 175 16
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dongbangftl.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    This week, SpeakPharma interviews Miquel Bachs, CEO of Inke, a company with over two decades of expertise in micronization and particle engineering, and a leader in providing high-quality, effective solutions in the global fight against chronic respiratory diseases such as COPD and asthma. In this insightful conversation, Bachs shares Inke’s strategic vision, technological innovations, and commitment to sustainability, offering a comprehensive look at how the company is shaping the future of respiratory health. HIGHLIGHTS// Inke’s strategic vision/ technological innovations/ commitment to sustainability Studies suggest that 13 percent of people over 40 years of age, the world over, have chronic obstructive pulmonary disease (COPD). Given the increasing prevalence of respiratory diseases, how does Inke position itself as a leader in the development and manufacturing of respiratory APIs? Inke has established itself as a global leader in generic respiratory API development through our unique blend  of technological innovation, expertise in micronization, and a comprehensive portfolio of inhalation therapies. With over 20 years of experience in micronization and particle engineering, our ability to customize APIs to meet specific client requirements has resulted in highly effective, high-quality products tailored for respiratory therapies. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has only underscored Inke’s pivotal role in supporting the pharmaceutical industry’s need for advanced treatments. We specialize in bronchodilators and other critical respiratory APIs that improve patient outcomes and meet the stringent regulatory requirements of global health authorities. Our end-to-end approach, from early-stage API development to commercial-scale production, ensures that we maintain the highest standards of quality, safety, and efficacy. As the market for respiratory APIs continues to evolve, Inke remains committed to expanding its portfolio to address unmet therapeutic needs. Beyond respiratory APIs, we are also prioritizing growth in CNS treatments and building on our expertise in complex molecule synthesis. This strategic focus allows us to provide an integrated solution that not only meets current market demands but also anticipates future pharmaceutical trends. HIGHLIGHTS// comprehensive portfolio of inhalation therapies/ over 20 years of experience in micronization and particle engineering/ specialize in bronchodilators and other critical respiratory APIs/ prioritizing growth in CNS treatments In the field of micronization, what differentiates Inke’s approach from that of other manufacturers of respiratory APIs? What sets Inke apart in micronization is our advanced particle size reduction technology and our dedication to precision. Our facility is equipped with various milling techniques such as Cone, Jet, and Pin mills, allowing us to reduce particle size while stabilizing the amorphous content to ensure consistent quality. Our in-depth understanding of respiratory APIs, combined with our ability to tailor solutions for each customer, results in APIs with improved solubility, stability, and bioavailability, which are critical for the efficacy of inhalation products. This, along with our exceptional quality standards and a flawless audit track record, has positioned us as a key partner for major players in the inhalation market. HIGHLIGHTS// advanced particle size reduction technology/ technological innovations/ tailor solutions/ improved solubility, stability, and bioavailability Developing complex APIs can be challenging. How does Inke ensure a smooth and successful partnership throughout the development and manufacturing process, including customization, ensuring regulatory compliance and timely delivery? At Inke, we are dedicated to fostering strong partnerships with our clients through a collaborative approach that prioritizes open communication and mutual understanding. Our commitment to quality and personalized service sets us apart in the pharmaceutical landscape. Our team takes the time to engage in comprehensive discussions to customize our solutions, ensuring alignment with client specifications across all batches and grades. This commitment to flexibility allows us to respond effectively to evolving requirements, solidifying Inke’s reputation as a reliable partner. We understand that navigating regulatory landscapes can be challenging. That's why our team is equipped to manage all aspects of the regulatory process with meticulous attention to detail. From the submission of Drug Master Files (DMFs) and Certificates of Suitability to crafting precise responses to potential Deficiency Letters, we ensure compliance at every step. Moreover, we offer extensive support in patent and intellectual property matters, providing technical assistance and guidance tailored to the specific requirements of each region. Our unwavering dedication to quality, coupled with our agile response capabilities, enables us to deliver exceptional results while maintaining transparency and trust. At Inke, we are committed to building lasting relationships that drive success for both our clients and our organization. HIGHLIGHTS// ensuring alignment with client specifications/ manage all aspects of the regulatory process/ support in patent and intellectual property matters Given Inke’s global presence, what are the key markets for growth and how does Inke plan to expand its market reach and strengthen its position in these regions? Inke is strategically focused on expanding its footprint in the European and US markets, where we continue to prioritize our efforts. The US market remains pivotal for us, especially considering our successful FDA inspections and ongoing regulatory compliance efforts that solidify our reputation. Japan is another significant market where we have established a robust presence, reflecting our commitment to high-quality manufacturing and innovation. Looking ahead, China represents a key growth opportunity for Inke. With 12 active DMFs registered, we are well-positioned to tap into this burgeoning market. Our strategy involves leveraging our existing capabilities to navigate regulatory landscapes and fostering strong partnerships within the region, thereby enhancing our market reach and influence in the pharmaceutical sector. HIGHLIGHTS// expanding footprint in the European and US markets/ China represents a key growth opportunity for Inke With Inke expanding into contract manufacturing organization (CMO) services, how does this new offering align with Inke’s broader strategic goals, and what advantages does it provide to pharmaceutical partners? At Inke, the introduction of CMO services is a natural extension of our core expertise in the development and manufacturing of high-quality generic APIs. Our expansion into CMO is part of a strategic move to diversify our service portfolio, allowing us to offer end-to-end solutions for our clients. The CMO service integrates seamlessly with our expertise in API manufacturing, particularly in micronization, which has been a key differentiator for Inke for over two decades. With our advanced particle engineering capabilities, we can offer tailored solutions that meet specific technical and regulatory requirements. Whether it is small-batch production or scaling up to commercial quantities, we offer the flexibility to accommodate a wide range of customer needs. This adaptability, paired with our deep expertise in micronization, allows us to support evolving project needs, maintaining the highest standards of consistency, quality, and performance that define Inke’s footprint. HIGHLIGHTS// CMO is part of a strategic move to diversify our service portfolio/ deep expertise in micronization What is Inke’s commitment to sustainability and corporate social responsibility and how is it integrating sustainable practices into its operations and product development? At Inke, we recognize that integrating environmental, social, and governance (ESG) principles into our operations is not just a responsibility but a pathway to long-term success. Our ESG vision is centered around aligning business growth with sustainable practices that positively impact our communities and the environment. We are dedicated to environmental responsibility, actively implementing initiatives such as efficient wastewater treatment and water reuse systems to minimize our ecological footprint. Our recent investments in energy efficiency include the installation of a 135 kWp solar panel system, which underscores our commitment to reducing emissions and resource consumption across our manufacturing and research facilities. Inke is also committed to fostering a diverse and inclusive workforce. With a notable increase in our team members, particularly in operations and quality assurance, we prioritize career development and the well-being of our employees. By adhering to high regulatory standards, we ensure our products meet stringent global requirements, enhancing our transparency and compliance. Through these initiatives, Inke aims to cultivate sustainable practices that not only support our business objectives but also contribute positively to the pharmaceutical industry and society at large. HIGHLIGHTS// integrating ESG principles/ efficient wastewater treatment and water reuse systems/ installation of a 135 kWp solar panel system/ diverse and inclusive workforce

    Impressions: 441

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

    #SpeakPharma With Inke
    28 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2508

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

    #PharmaFlow by PHARMACOMPASS
    24 Oct 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Entecavir

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Entecavir

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2018-093 - Rev 00

    Issue Date : 2020-04-09

    Type : Chemical

    Substance Number : 2815

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10257

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2015-10-21

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Ketoprofen

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Ketoprofen

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-120 - Rev 01

    Issue Date : 2016-12-19

    Type : Chemical

    Substance Number : 922

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10042

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2014-02-19

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Ketoprofen

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Ketoprofen

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-194 - Rev 03

    Issue Date : 2024-04-17

    Type : Chemical

    Substance Number : 922

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10706

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2006-08-11

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Olmesartan Medoxomil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Olmesartan Medoxomil

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2015-237 - Rev 01

    Issue Date : 2024-10-02

    Type : Chemical

    Substance Number : 2600

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10074

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2014-03-11

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Tamsulosin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Tamsulosin

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-178 - Rev 00

    Issue Date : 2024-04-16

    Type : Chemical

    Substance Number : 2131

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 230MF10019

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2018-02-05

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Celecoxib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Celecoxib

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2015-185 - Rev 00

    Issue Date : 2022-02-14

    Type : Chemical

    Substance Number : 2591

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Mefenamic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Mefenamic Acid

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-296 - Rev 06

    Issue Date : 2021-12-15

    Type : Chemical

    Substance Number : 1240

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Pregabalin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Pregabalin

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2018-148 - Rev 00

    Issue Date : 2020-05-19

    Type : Chemical

    Substance Number : 2777

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Rivaroxaban

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Rivaroxaban

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2021-211 - Rev 00

    Issue Date : 2023-08-21

    Type : Chemical

    Substance Number : 2932

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Sitagliptin Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Sitagliptin Phosphate

    South Korea

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-028 - Rev 02

    Issue Date : 2024-06-28

    Type : Chemical

    Substance Number : 2778

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Celecoxib

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    02

    Entecavir monohydrate

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    03

    Ketoprofen

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    04

    Ketoprofen, Process N

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    05

    Mefenamic acid

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    06

    Olmesartan medoxomil

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    07

    Pregabalin

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    08

    Rivaroxaban

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    09

    Sitagliptin phosphate monohydrate

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    10

    Solifenacin succinate

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Entecavir

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Entecavir

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 227MF10257

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2015-10-21

    Latest Date of Registration : 2016-11-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Felbinac

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Felbinac

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 224MF10041

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2012-02-28

    Latest Date of Registration : 2012-02-28

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Japanese Pharmacopoeia ketoprofen (produ...

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Japanese Pharmacopoeia ketoprofen (produ...

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 218MF10706

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2006-08-11

    Latest Date of Registration : 2006-08-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    KETOPROFEN

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    KETOPROFEN

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 226MF10042

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2014-02-19

    Latest Date of Registration : 2014-02-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Levofloxacin

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Levofloxacin

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 222MF10053

    Registrant's Address : 904-5, Sangsin ri, Hyangnam eup, Hwasung si, Kyonggi do, 445-922, Korea

    Initial Date of Registration : 2010-02-12

    Latest Date of Registration : 2010-02-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Loxoprofensodium hydrate

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Loxoprofensodium hydrate

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 224MF10015

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2012-01-18

    Latest Date of Registration : 2012-01-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    MELOXICAM

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    MELOXICAM

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 219MF10075

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2007-03-14

    Latest Date of Registration : 2007-03-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Mitiglinide calcium hydrate

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Mitiglinide calcium hydrate

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 229MF10057

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2017-03-03

    Latest Date of Registration : 2017-04-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Olmesartan medoxomil

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Olmesartan medoxomil

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 226MF10074

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2014-03-11

    Latest Date of Registration : 2021-12-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Propiverine hydrochloride

    JDMF

    SupplySide West 2024
    Not Confirmed
    arrow

    Propiverine hydrochloride

    South Korea
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DONG BANG FUTURE TECH & LIFE CO., LTD

    Registration Number : 229MF10050

    Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea

    Initial Date of Registration : 2017-02-22

    Latest Date of Registration : 2017-02-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    LISTED APIs

    read-more
    read-more
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

      4-BIPHENYLACETIC ACID

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
      blank

      01

      4-BIPHENYLACETIC ACID

      South Korea
      SupplySide West 2024
      Not Confirmed
      arrow

      4-BIPHENYLACETIC ACID

      South Korea
      arrow
      SupplySide West 2024
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

      DONG BANG FUTURE TECH & LIFE CO., LTD

      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

      About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

      blank

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

        Azintamide

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
        blank

        02

        Azintamide

        South Korea
        SupplySide West 2024
        Not Confirmed
        arrow

        Azintamide

        South Korea
        arrow
        SupplySide West 2024
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

        DONG BANG FUTURE TECH & LIFE CO., LTD

        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

        About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

        blank

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

          Bosentan

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
          DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
          blank

          03

          Bosentan

          South Korea
          SupplySide West 2024
          Not Confirmed
          arrow

          Bosentan

          South Korea
          arrow
          SupplySide West 2024
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

          DONG BANG FUTURE TECH & LIFE CO., LTD

          DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

          About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

          blank

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

            Celecoxib

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
            DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
            blank

            04

            Celecoxib

            South Korea
            SupplySide West 2024
            Not Confirmed
            arrow

            Celecoxib

            South Korea
            arrow
            SupplySide West 2024
            Not Confirmed
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

            DONG BANG FUTURE TECH & LIFE CO., LTD

            DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

            About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

            blank

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

              Cinacalcet Hydrochloride

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
              DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
              blank

              05

              Cinacalcet Hydrochloride

              South Korea
              SupplySide West 2024
              Not Confirmed
              arrow

              Cinacalcet Hydrochloride

              South Korea
              arrow
              SupplySide West 2024
              Not Confirmed
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

              DONG BANG FUTURE TECH & LIFE CO., LTD

              DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

              About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

              blank

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                Diclofenac Sodium

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
                DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
                blank

                06

                Diclofenac Sodium

                South Korea
                SupplySide West 2024
                Not Confirmed
                arrow

                Diclofenac Sodium

                South Korea
                arrow
                SupplySide West 2024
                Not Confirmed
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                DONG BANG FUTURE TECH & LIFE CO., LTD

                DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

                About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

                blank

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Contact Supplier
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                  Entecavir

                  Product
                  Web Link

                  Stock Recap
                  #PipelineProspector

                  Market
                  Place

                  DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
                  DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
                  blank

                  07

                  Entecavir

                  South Korea
                  SupplySide West 2024
                  Not Confirmed
                  arrow

                  Entecavir

                  South Korea
                  arrow
                  SupplySide West 2024
                  Not Confirmed
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                  DONG BANG FUTURE TECH & LIFE CO., LTD

                  DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

                  About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

                  blank

                  Product
                  Web Link

                  Stock Recap
                  #Pipeline Prospector

                  Market
                  Place

                  Contact Supplier
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                    Ezetimibe

                    Product
                    Web Link

                    Stock Recap
                    #PipelineProspector

                    Market
                    Place

                    DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
                    DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
                    blank

                    08

                    Ezetimibe

                    South Korea
                    SupplySide West 2024
                    Not Confirmed
                    arrow

                    Ezetimibe

                    South Korea
                    arrow
                    SupplySide West 2024
                    Not Confirmed
                    • fda
                    • EDQM
                    • WHO-GMP
                    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                    DONG BANG FUTURE TECH & LIFE CO., LTD

                    DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

                    About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

                    blank

                    Product
                    Web Link

                    Stock Recap
                    #Pipeline Prospector

                    Market
                    Place

                    Contact Supplier
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                      Fexofenadine Hydrochloride

                      Product
                      Web Link

                      Stock Recap
                      #PipelineProspector

                      Market
                      Place

                      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
                      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
                      blank

                      09

                      Fexofenadine Hydrochloride

                      South Korea
                      SupplySide West 2024
                      Not Confirmed
                      arrow

                      Fexofenadine Hydrochloride

                      South Korea
                      arrow
                      SupplySide West 2024
                      Not Confirmed
                      • fda
                      • EDQM
                      • WHO-GMP
                      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                      DONG BANG FUTURE TECH & LIFE CO., LTD

                      DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

                      About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

                      blank

                      Product
                      Web Link

                      Stock Recap
                      #Pipeline Prospector

                      Market
                      Place

                      Contact Supplier
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                        Gabapentin

                        Product
                        Web Link

                        Stock Recap
                        #PipelineProspector

                        Market
                        Place

                        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and h...
                        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
                        blank

                        10

                        Gabapentin

                        South Korea
                        SupplySide West 2024
                        Not Confirmed
                        arrow

                        Gabapentin

                        South Korea
                        arrow
                        SupplySide West 2024
                        Not Confirmed
                        • fda
                        • EDQM
                        • WHO-GMP
                        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                        DONG BANG FUTURE TECH & LIFE CO., LTD

                        DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.

                        About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that pr...

                        blank

                        Product
                        Web Link

                        Stock Recap
                        #Pipeline Prospector

                        Market
                        Place

                        Only 10 entries up to this point, click to access all click full view read-more
                        click full view
                        Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

                        ABOUT THIS PAGE

                        Contact DONG BANG FUTURE TECH & LIFE CO., LTD and get a quotation

                        DONG BANG FUTURE TECH & LIFE CO., LTD is a supplier offers 36 products (APIs, Excipients or Intermediates).

                        Find a price of Entecavir bulk with CEP, JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Ketoprofen bulk with CEP, JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Olmesartan Medoxomil bulk with CEP, JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Tamsulosin bulk with CEP, JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of 4-Biphenylacetic Acid bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Celecoxib bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Levofloxacin bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Loxoprofen Sodium bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Maleic Acid bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Mefenamic Acid bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Meloxicam bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Mitiglinide Calcium bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Pregabalin bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Propiverine Hydrochloride bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Rivaroxaban bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Silodosin bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Sitagliptin Phosphate bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Solifenacin Succinate bulk with CEP offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Telmisartan bulk with JDMF offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Azintamide bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Bosentan Hydrate bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Cinacalcet Hydrochloride bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Diclofenac Sodium bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Ezetimibe bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Fexofenadine Hydrochloride bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Gabapentin bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Hexoprenaline bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Imidafenacin bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Irsogladine Maleate bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Naftopidil bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Prasugrel Hydrochloride bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Sofosbuvir bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Tadalafil bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Tenofovir Disoproxil Fumarate bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Ticagrelor bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Find a price of Vildagliptin bulk offered by DONG BANG FUTURE TECH & LIFE CO., LTD

                        Ask Us for Pharmaceutical Supplier and Partner
                        Ask Us, Find A Supplier / Partner
                        No Commissions, No Strings Attached, Get Connected for FREE

                        What are you looking for?

                        How can we help you?

                        The request can't be empty

                        Please read our Privacy Policy carefully

                        You must agree to the privacy policy

                        The name can't be empty
                        The company can't be empty.
                        The email can't be empty Please enter a valid email.
                        The mobile can't be empty

                        Market Place

                        Market Place

                        PharmaCompass

                        Home

                        Market Place

                        Menu

                        Post Enquiry

                        Post Enquiry

                        Market Place

                        Market Place

                        Search